Blueprint Medicines

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BPMC and other ETFs, options, and stocks.

About BPMC

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. 

CEO
Kathryn Haviland
CEOKathryn Haviland
Employees
655
Employees655
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2008
Founded2008
Employees
655
Employees655

BPMC Key Statistics

Market cap
6.57B
Market cap6.57B
Price-Earnings ratio
-21.77
Price-Earnings ratio-21.77
Dividend yield
Dividend yield
Average volume
554.81K
Average volume554.81K
High today
$107.17
High today$107.17
Low today
$103.23
Low today$103.23
Open price
$106.96
Open price$106.96
Volume
399.90K
Volume399.90K
52 Week high
$111.02
52 Week high$111.02
52 Week low
$43.89
52 Week low$43.89

BPMC News

Seeking Alpha 5d
Blueprint Medicines started at buy by Stephens, citing Ayvakit franchise

Stephens started coverage of Blueprint Medicines (NASDAQ:BPMC) with a buy rating and a place on its best idea list. The investment firm said it views the compa...

Blueprint Medicines started at buy by Stephens, citing Ayvakit franchise

Analyst ratings

72%

of 18 ratings
Buy
72.2%
Hold
22.2%
Sell
5.6%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.